Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T) Meeting Abstract
| Authors: | Bock, A. M.; Raj, S.; Giri, S.; Leslie, L. A.; Patel, D. A.; Iqbal, M.; Grover, N. S.; Hu, B.; Perales, M. A.; Nowakowski, G. S. |
| Abstract Title: | Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406351 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.TPS7100 |
| Notes: | Meeting Abstract: TPS7100 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work